Breathtec Biomedical Inc Stock Deutsche Boerse AG
Equities
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.6M 2.44M |
---|---|---|---|---|---|
Net income 2022 | -6M -5.63M | Net income 2023 | -6M -5.63M | EV / Sales 2022 | - |
Net cash position 2022 | 1.41M 1.32M | Net cash position 2023 | 125K 117K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.55
x | P/E ratio 2023 |
-0.37
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
James Kinley
DFI | Director of Finance/CFO | 45 | 21-11-30 |
Chief Operating Officer | 41 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 21-09-07 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
Mark Williams
BRD | Director/Board Member | 52 | 21-09-21 |
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |